Others have shown that germ-free or conventional mice with antibiotic treatment are protected from lung cancer development that is otherwise triggered by Kras mutation and the loss of p53 if lung microbiota is not distorted by antibiotics [138]. Here, TP53 is linked to lung carcinoma.